The aggregation of amyloid P peptide (AP) into its fibrillar, cross P-pleated configuration is generally viewed as a critical event in the pathophysiology of Alzheimer's disease (AD). A diverse group of molecules, the AP binding proteins, has been evaluated for their effects on this process. However
Enhanced aggregation and β structure of amyloid β peptide after coincubation with C1Q
✍ Scribed by S. Webster; S. O'Barr; Dr. J. Rogers
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 897 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0360-4012
No coin nor oath required. For personal study only.
✦ Synopsis
Several lines of evidence now suggest that aggregation of soluble amyloid P peptide (AD) into a cross P sheet configuration may be an important factor in mediating potential neurotoxicity of AP. Synthetic AP has been shown to self aggregate in vitro. Here, we demonstrate that coincubation of freshly solubilized AP with Clq, a complement component known to bind AP in vitro and to colocalize with AP in vivo, results in as much as a 7-fold enhancement of AP aggregation, as well as a 2 4 f o l d enhancement of P structure within aggregates. The addition of Clq to preformed AP aggregates also results in significantly increased resistance to aggregate resolubilization.
📜 SIMILAR VOLUMES
Alzheimers disease (AD) is the most frequent cause of late-life dementia, with pathological characteristics of extracellular aggregation of amyloid b-peptides (Abs) with 39 ± 43 amino acids, which are proteolytically derived from the transmembrane amyloid precursor protein (APP). [1] Recent studies